SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
zhangyue092200
Lv3
1
320 积分
2024-09-06 加入
最近求助
最近应助
互助留言
Cyclopeptide RA-V from Rubia yunnanensis restores activity of Adagrasib against colorectal cancer by reducing the expression of Nrf2
25天前
已完结
Prognostic value of specific KRAS mutations in patients with colorectal peritoneal metastases
25天前
已完结
Increased KRAS G12C Prevalence, High Tumor Mutational Burden, and Specific Mutational Signatures Are Associated With MUTYH Mutations: A Pan-Cancer Analysis
25天前
已完结
Another KRAS Inhibitor Holds Its Own
25天前
已关闭
Computational insights into KRAS G12C inhibition: exploring possible repurposing of Azacitidine and Ribavirin
25天前
已完结
A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C)
25天前
已完结
A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor
25天前
已完结
Identification of KRASG12C Mutations in Circulating Tumor DNA in Patients With Cancer
26天前
已完结
Dueling KRASG12C Inhibitors Achieve Responses
26天前
已完结
Divarasib Plus Cetuximab Is Safe and Has Efficacy in Colorectal Cancer
26天前
已关闭
没有进行任何应助
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
帮大忙了
26天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论